|  |  | Univariate analysis | Multivariate analysis | |
---|---|---|---|---|---|
Characteristics | No. of patients | 5-y DFS (%) | P | Relative risk (95% CI) | P |
Cervical tumor size | Â | Â | Â | Â | Â |
   ≥5 cm | 14 | 69.2 | 0.50 | 0.66 | 0.53a |
   < 5 cm | 15 | 80.0 |  | (0.18 – 2.42) |  |
Clinical node involvement | Â | Â | Â | Â | Â |
   Yes | 11 | 70.6 | 0.49 | 2.30 | 0.39 |
   No | 18 | 81.8 |  | (0.35 – 15.10) |  |
Stage | Â | Â | Â | Â | Â |
   IB2 | 20 | 73.3 | 0.83 | 0.67 | 0.64 |
   IIA | 9 | 77.8 |  | (0.13 – 3.58) |  |
SCC Ag level | Â | Â | Â | Â | Â |
   ≥5 ng/ml | 14 | 69.2 | 0.50 | 1.03 | 0.45a |
   < 5 ng/ml | 15 | 80.0 |  | (0.95 – 1.12) |  |
VEGF expression | Â | Â | Â | Â | Â |
   Negative | 14 | 92.3 | 0.033 | 11.40 | 0.037 |
   Positive | 15 | 60.0 |  | (1.15 – 112.58) |  |